HRAS and vascular malformation: Of the 8 variants identified, 7 involved the RAS-MEK pathway (KRAS, MAP2K1, HRAS) and one involved the PIK3CA-mTOR pathway (PIK3CA), the latter of which is more often implicated in low-flow vascular malformations; see Fig. 2.